前田裕弘

前田 裕弘（まえだ やすひろ、1955年3月9日 - ）は日本の医師。専門は血液内科、免疫内科。日本血液学会 血液専門医・指導医、日本エイズ学会 指導医、日本臨床免疫学会 免疫療法認定医。最終学歴は近畿大学。

**来歴**
大阪府河内長野市生まれ。医学博士。1980年3月近畿大学医学部卒、同年6月同大学医学部第三内科学教室入局。同教室の講師に。その後、米国に渡りワシントン大学医学部病理学教室入局。日本に戻り近畿大学医学部の助教授を経て教授に。血液病理学、移植学、がん薬物療法、エイズ、免疫療法学に研鑽、現場に従事。

**経歴**
1980年3月　近畿大学医学部卒業
*1980年6月　近畿大学医学部第三内科学教室入局
*1982年4月　同教室助手
*1987年4月　京都大学医学部免疫研究施設Ｉ
*1989年4月　近畿大学医学部第三内科学教室講師
*1990年4月　米国ワシントン大学医学部病理学教室（ｾﾝﾄﾙｲｽ）
*2002年4月　近畿大学医学部血液・腎臓・膠原病内科助教授
*2008年10月　近畿大学医学部教授
*2011年4月　近畿大学医学部客員教授
*2011年4月　国立病院機構大阪南医療センター　がん疾患センター部長
*2016年4月　国立病院機構大阪南医療センター特命副院長併任
*2020年4月　医療法人浩仁会南堺病院　病院長
*2021年8月　医療法人敬任会南河内おか病院　副院長
*2023年6月　医療法人社団日翔会まえだクリニック　院長

**所属学会**
日本血液学会　血液専門医・指導医
*日本臨床血液学会　評議員
*日本臨床腫瘍学会　暫定指導医
*日本移植学会　認定医
*日本エイズ学会　認定医・指導医
*日本臨床免疫学会　免疫療法認定医
*日本感染症学会　インフェクションコントロールドクター
*日本再生医療学会　評議員
*日本HTLVーI学会　評議員
*日本癌学会
*日本内科学会
*欧州血液学会　
*米国血液学会
*国際実験血液学会

**研究者**
 日本の研究.com  研究者ID : 231197- KAKEN　研究者番号 :  10173717- J-GLOBAL ID：200901031844131608

**論文**
Akinobu Tojo, Yasuhiro Maeda, et al.「A phase I/II study of nilotinib in Japanese patients with imatinib-resistant or-intolerant Ph+ CML or relapsed/refractory Ph+ ALL.」『International Journal of Hematology』. 89:679-688, 2009 
*Ohyashiki K, Maeda Y, et al.「Increased natural killer cells and decreased CD3(+) CD8(+) CD62L(+) T cells in CML patients who sustained complete molecular remission after discontinuation of imatinib.」『	British J Haematology』157:254-256, 2012 
*Kensuke Usuki, Yasuhiro Maeda, et al.「Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL: a 36-month analysis of a phase I and II study.」『International journal of hematology』95:409-19, 2012
*Kazunori Ohnishi, Yasuhiro Maeda, et al.「Long-term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 study.」『Cancer Science』103: 1071-1078, 2012
*Yasuhiro Maeda, et al.「Improved drug adherence in patients with chronic myeloid leukemia in chronic phase by switching to second-generation tyrosin kinase inhibitors.」『Acta Haematologica』138 (3):140-142, 2017
*Shin Fujisawa, Yasuhiro Maeda, et al.「Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial).」『International Journal of Clinical Oncology』2019 Apr; 24(4):445-453.
*Yasuhiro Maeda, et al.「Clinical Importance of Drug Adherence during Tyrosine Kinase Inhibitor Therapy for Chronic Myelogenous Leukemia in Chronic Phase.」『Reports 2019』2, 25; doi:10.3390/reports2040025
*Yasuhiro Maeda, et al.「Investigation about down-regulation of CD3 antigen on adult T cell leukemia cells. Flow Cytometry and Image Analysis for Clinical Applications.」『Elsevier Science Publishers B.V.』1991, p247-252
*Mitsuhiro Matsuda, Yasuhiro Maeda, et al.「CD3 down-regulating factor in sera and culture supernatants of leukemic cells from the patients with adult T cell leukemia.」『British J. Haematol.』83: 212-217, 1993
*Mitsuhiro Matsuda, Yasuhiro Maeda, et al.「Possible involvement of protein kinase C activation in down-regulation of CD3 antigen on adult T cell leukemia cells.」『British Journal of Haematology』86: 399-401, 1994
*Yasuhiro Maeda, et al.「The down-regulation of CD3 antigen on Adult T cell Leukemia cells.」『Leukemia and Lymphoma』13: 249-256, 1994
*Yasuhiro Maeda, et al.「13-cis retinoic acid Inhibits growth of adult T cell leukemia cells and causes apoptosis ; possible new indicator for retinoid therapy.」『Internal Medicine』35: 180-184, 1996
*Yasuhiro Maeda, et al.「New Therapeutic effects of retinoid for adult T cell leukemia.」『BLOOD』88: 4726-4727, 1996
*Jun-ichi Miyatake and Yasuhiro Maeda.「Retinoid induces growth inhibition of adult T-cell leukemia cells.」『Acta Medica Kinki University』22:111-121, 1997
*Jun-ichi Miyatake and Yasuhiro Maeda.「Inhibition of proliferation and CD25 down-regulation by retinoic acid in human adult T cell leukemia cells.」『Leukemia』11: 401-407, 1997
*Jun-ichi Miyatake, Yasuhiro Maeda, et al.「Thiol compounds rescue growth inhibition by retinoic acid on HTLV-I (+) T lymphocytes; possible mechnism of retinoic acid induced growth inhibition of adult T cell leukemia.」『Hematopathology and Molecular Hematology』11(2): 89-99, 1998
*Jun-ichi Miyatake, Yasuhiro Maeda, et al.「Important role of thiol compounds to protect oxidative stress on HTLV-I(+) T lymphocytes.」『Leukemia Res』24(3): 265-266, 2000
*Yasuhiro Maeda, et al.「Clinical application of all-trans retinoic acid (Tretinoin) for adult T cell leukemia.」『Br. J. Haematol』109: 677-678, 2000
*Hiroyuki Nawata, Yasuhior Maeda, et al.「A mechanism of apoptosis induced by all-trans retinoic acid on adult T-cell leukemia cells: a possible involvement of the Tax/NF-kappaB signaling pathway.」『Leukemia Res』25(4): 323-331, 2001
*Yasuhiro Maeda, et al.「All-trans retinoic acid reduced skin involvement of adult T-cell leukemia.」『Leukemia』18: 1159-1160, 2004
*Terufumiu Yamaguchi, Yasuhiro Maeda, et al.「Dichotomy of all-trans retinoic acid inducing signals for adult T-cell leukemia.」『Leukemia』19:1010-7, 2005
*Yasuhiro Maeda, et al.「Clinical efficacy of all-trans retinoic acid for treating adult T-cell leukemia.」『Journal of Cancer Reseaech of Clinical Oncology』134:673-677, 2008
*Satomi Ueda, Yasuhiro Maeda, et al.「Influences of Epstein-Barr virus infection in adult T-cell leukemia.」『Hematology』13:154-162, 2008
*Chikara Hirase, Yasuhiro Maeda, et al.「Hypersensitivity pf Ph-positive lymphoid cell lines tp rapamycin: Possible clinical application of mTOR inhibitor.」『Leukemia Res』33:450-459, 2009
*Chikara Hirase, Yasuhiro Maeda, et al.「mTOR inhibition and adult T-cell leukemia.」『Leukemia and Lymphoma』50:645-647, 2009
*Yasuhiro Maeda.「Retrovirus infection and retinoid. (Review).」『Acta Med Kinki Univ』34:1-13, 2009
*Chen Z, Maeda Y, et al.「Thioredoxin-binding protein-2 (TBP-2/VDUP1/TXNIP) regulates T-cell sensitivity to glucocorticoid during HTLV-I-induced transformation.」『Leukemia』25:440-448, 2011
*Yasuhiro Maeda, et al.「Senescence induction therapy for the treatment of adult T-cell leukemia.」『Leukemia and Lymphoma』52:150-152, 2011
*Yasuhiro Maeda, et al.「Retrovirus infection and retinoid.」『T-cell leukemia. Edited by Olga Babusikova et al. InTECH』2011
*Yasuhiro Maeda, et al.「Cellular senescence induction by retinoid on adult T-cell leukemia cells.」『Retrovirology 2011』2011, 8(Suppl 1):A31 (6 June 2011)
*Yasuhiro Maeda, et al.「Effects of tamibarotene for treatment of adult T-cell leukemia.」『Ann Hematology』91:629-631，2012
*Yasuyo Ohyama, Yasuhiro Maeda., et al.「Induction of molecular remission by using anti-CC-chemokine receptor 4 (anti-CCR4) antibodies for adult T-cell leukemia: a risk of opportunistic infection after treatment with anti-CCR4 antibodies.」『Ann Hematology』93:169-71, 2014
*Yasuhiro Maeda, et al.「Relationship between Cellular Senescence and Redox Potential on Adult T-Cell Leukemia Cells.」『Journal of Blood Research & Hematologic Diseases』 1:1.doi:10.4172/jbrhd.1000101
*Yasuhiro Maeda, et al.「Adult T-Cell Leukemia and Retinoid.」『Journal of Hematology Research』2016.3:1-5
*Yasuhiro Maeda, et al.「Deleted mutation of GSTT-1 gene in patients with MDS.」『Leukemia』12(12): 2039, 1998
*Mitsuhiro Matsuda, Yasuhiro Maeda, et al.「Establishment of a myelodysplastic syndrome (MDS)/ secondary AML-derived T lymphoid cell line K2-MDS.」『Leukemia Res』24:103-108, 1999
*Yoshiyasu Sumimoto, Yasuhiro Maeda, et al.「Establishment of a myeloid cell line, YM711, characterized by retinoid resistance.」『Leukemia and Lymphoma』39: 373-383, 2000
*Hajime Miyazato, Yasuhiro Maeda, et al.「Detection of myeloperoxidase gene expression by in situ hybridization in a case of granulocytic sarcoma associated with AML-M0.」『Leukemia』16:1797-1799, 2001
*Mitsuhiro Matsuda, Yasuhiro Maeda, et al.「Mitsuhiro Matsuda, Yasuhiro Maeda, et al.」『Int. J. Hematol』75: 335-336, 2002
*Yasuhiro Maeda, et al.「Mutant type of glutathione S-transferase theta 1 gene homologue to mTOR in myelodysplastic syndrome :possible clinical application od rapamycin.」『Leukemia and Lymphoma』44: 1179-1185, 2003
*Mitsuhiro Matsuda, Yasuhiro Maeda, et al.「CD34+ progenitors from MDS patients are unresponsive to SDF-1, despite high levels of SDF-1 in bone marrow plasma.」『	Leukemia』18: 1038-1040, 2004
*Yasuyoshi Morita, Yasuhiro Maeda, et al.「A perforin/granzyme-positive MDS-derived T cell line, K2-MDS, induces apoptosis in CD34(+) cells through the fractalkine-CX3CR1 system.」『Clin Immunol』113:109-116, 2004
*Mitsuhiro Matsuda, Yasuhiro Maeda, et al.「Extramedullary blast crisis derived from 2 different clones in the central nervous system and neck during complete cytogenetic remission of chronic myelogenous leukemia treated with Imatinib mesylate.」『International Journal of Hematology』81: 307-309, 2005
*Yasuhiro Maeda, et al.「Possible molecular target therapy with rapamycin in MDS.」『Leukemia and Lymphoma』47: 907-911, 2006
*Yasuhiro Maeda, et al.「Relationship between expression of mutant type glutathione S-transferase theta-1 gene and reactivity of rapamycin in myelodysplastic syndrome.」『Hematology』14:266-270, 2009
*Yasuyoshi Morita, Yasuhiro Maeda, et al.「A case of chronic myelomonocytic leukemia who developed pericardial effusion during stably controlled leukocytosis.」『Internal Medicine』50:1737-1740, 2011　Retrovirology 8:100, 2011
*Takahiro Kumode, Yasuhiro Maeda et al.「A case of secondary leukemia subsequent to myelodysplastic syndromes successfully treated with azacitidine.」『Case Reports in Medicine』Volume 2014, Article ID 793928, 3 pages
*Yasuhiro Maeda, et al.「Transient eosinophilia by HIV infection.」『Ann. Hematol』79(2): 99-101, 2000
*Yasuhiro Maeda, et al.「Herbs for HIV infection.」『Am J Hematol』70:263-264, 2002
*Yasuhiro Maeda, et al.「All-trans retinoic acid attacks reverse transcriptase resulting in inhibition of HIV-1 replication.」『Hematology』12:263-266, 2007
*Atsushi Sasakawa, Yasuhiro Maeda, et al.「Interleukin-8 in the pathogenesis of primary central nervous system lymphoma in association with HIV infection.」『Hematology』17:144-150, 2012
*前田裕弘「ステロイド投与中の高脂血症の治療」『診療と新薬』61：15-18, 2024
*CiNii収録論文 - CiNii
**https://cir.nii.ac.jp/articles?q=%E5%89%8D%E7%94%B0%E8%A3%95%E5%BC%98

**著書**
『血液疾患における多職種の関わり : ５つの症例から考えるチーム医療の実際』中外医学社、2020年4月7日。978-4498225206
*『ウィルスとインターフェロン』慢性肝炎のインターフェロン療法(日本医学館) 1993年。
*『Investigation about down-regulation of CD3 antigen on adult T cell leukemia cells』Flow cytometry and Image analysis for Clinical Application Elsevier Science Publisher 1991
*『Signal transduction through FcεR2/Cd23 ; Induction of IL-2R/p55(Tac) by stimulation of Fc R2/Cd23』Luekocyte Typing Oxford University Press

**脚注**

**出典 ===